Simon E. G.
Ustekinumab: a novel therapeutic option in Crohn's disease
E. G., Simon; S., Samuel; S., Ghosh; G. W., Moran
Citation
E. G., S., S., S., S., G., & G. W., M. (2016). Ustekinumab: a novel therapeutic option in Crohn's disease. Expert Opinion on Biological Therapy, 16(8), 1065-1074. https://doi.org/10.1080/14712598.2016.1205582
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 20, 2016 |
Online Publication Date | Jul 6, 2016 |
Publication Date | Jun 24, 2016 |
Deposit Date | Dec 13, 2018 |
Print ISSN | 1471-2598 |
Electronic ISSN | 1744-7682 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Volume | 16 |
Issue | 8 |
Pages | 1065-1074 |
DOI | https://doi.org/10.1080/14712598.2016.1205582 |
Keywords | Anti-TNF agents; biologic therapy; Crohn’s disease; ustekinumab |
Public URL | https://nottingham-repository.worktribe.com/output/1413174 |
Publisher URL | https://www.tandfonline.com/doi/full/10.1080/14712598.2016.1205582 |
You might also like
Clinical predictors of thiopurine-related adverse events in Crohn's disease
(2015)
Journal Article
Colectomy is a risk factor for venous thromboembolism in ulcerative colitis
(2015)
Journal Article
Orbital inflammatory complications of Crohn’s disease: a rare case series
(2018)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search